#27 - David Sinclair, Ph.D.: Slowing aging – sirtuins, NAD, and the epigenetics of aging
The Peter Attia Drive
00:00
Resvertol
Resvertol itself was considered a proof of concept molecule, largely if it ended up in the clinic imean as a drug. But we what we you onduation was, it might be, it might not. So that was a gall and there were some very good formulation chemists who were trying to work out ways to make revertal absorbable in the body. It allowed us to get into humans and see what would happen. Do we see the same kinds of things, or could we deliver it on the skin or in the eye? There was nothing. A couple of patients in a kansas study that had renal failure, which happens anyway, in these late stage patients.
Transcript
Play full episode
